MX2009010910A - Regulacion autoinmune de cancer de prostata por anexina a3. - Google Patents
Regulacion autoinmune de cancer de prostata por anexina a3.Info
- Publication number
- MX2009010910A MX2009010910A MX2009010910A MX2009010910A MX2009010910A MX 2009010910 A MX2009010910 A MX 2009010910A MX 2009010910 A MX2009010910 A MX 2009010910A MX 2009010910 A MX2009010910 A MX 2009010910A MX 2009010910 A MX2009010910 A MX 2009010910A
- Authority
- MX
- Mexico
- Prior art keywords
- annexin
- prostate cancer
- autoimmune
- regulation
- autoimmune regulation
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4718—Lipocortins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se relaciona con un método para el diagnóstico de carcinoma de próstata que comprende la determinación de anexina A3 (ANXA3) y/o autoanticuerpos contra ANXA3 con un reactivo específico. El método permite la diferenciación entre condiciones benigna, premaligna y maligna. Además, el método tiene relevancia como pronóstico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91132907P | 2007-04-12 | 2007-04-12 | |
PCT/EP2008/002802 WO2008125262A1 (en) | 2007-04-12 | 2008-04-09 | Autoimmune regulation of prostate cancer by annexin a3 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009010910A true MX2009010910A (es) | 2010-01-20 |
Family
ID=39537945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009010910A MX2009010910A (es) | 2007-04-12 | 2008-04-09 | Regulacion autoinmune de cancer de prostata por anexina a3. |
Country Status (11)
Country | Link |
---|---|
US (1) | US8377648B2 (es) |
EP (1) | EP2135084A1 (es) |
JP (1) | JP2010523990A (es) |
KR (1) | KR20100015421A (es) |
CN (1) | CN101669032A (es) |
AU (1) | AU2008238258B2 (es) |
BR (1) | BRPI0810176A2 (es) |
CA (1) | CA2682899A1 (es) |
MX (1) | MX2009010910A (es) |
RU (1) | RU2484482C2 (es) |
WO (1) | WO2008125262A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2176665B1 (en) | 2007-08-16 | 2016-03-02 | The Royal Institution for the Advancement of Learning / McGill University | Tumor cell-derived microvesicles |
US20100255514A1 (en) | 2007-08-16 | 2010-10-07 | The Royal Institution For The Advancement Of Learning/Mcgill University | Tumor cell-derived microvesicles |
GB2478734A (en) * | 2010-03-15 | 2011-09-21 | Sense Proteomic Ltd | Auto-antibody biomarkers of prostate cancer |
GB201105129D0 (en) * | 2011-03-28 | 2011-05-11 | Univ Surrey | Compositions and methods for treating, diagnosing and monitoring disease |
US20130040839A1 (en) * | 2011-06-27 | 2013-02-14 | Ambergen, Inc. | Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery |
WO2013076222A1 (en) | 2011-11-23 | 2013-05-30 | Proteosys Ag | Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer |
CN104897900B (zh) * | 2014-03-03 | 2018-03-27 | 昂科生物医学技术(苏州)有限公司 | 一种前列腺小体外泄蛋白抗原及其抗体与应用 |
US20240011996A1 (en) * | 2020-11-24 | 2024-01-11 | Korea Institute Of Science And Technology | Biomarkers for diagnosing prostate cancer, combination thereof, and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030108963A1 (en) * | 2001-07-25 | 2003-06-12 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer |
GB2395270B (en) | 2002-11-14 | 2006-08-16 | Univ Nottingham | Tumour marker proteins and uses thereof |
EP1724586A3 (en) * | 2005-05-21 | 2007-07-04 | ProteoSys AG | Annexin for cancer risk assessment |
-
2008
- 2008-04-09 RU RU2009141703/15A patent/RU2484482C2/ru not_active IP Right Cessation
- 2008-04-09 AU AU2008238258A patent/AU2008238258B2/en not_active Expired - Fee Related
- 2008-04-09 CA CA002682899A patent/CA2682899A1/en not_active Abandoned
- 2008-04-09 EP EP08735114A patent/EP2135084A1/en not_active Withdrawn
- 2008-04-09 WO PCT/EP2008/002802 patent/WO2008125262A1/en active Application Filing
- 2008-04-09 BR BRPI0810176-0A2A patent/BRPI0810176A2/pt not_active IP Right Cessation
- 2008-04-09 KR KR1020097020948A patent/KR20100015421A/ko not_active Application Discontinuation
- 2008-04-09 MX MX2009010910A patent/MX2009010910A/es active IP Right Grant
- 2008-04-09 US US12/595,678 patent/US8377648B2/en not_active Expired - Fee Related
- 2008-04-09 JP JP2010502455A patent/JP2010523990A/ja active Pending
- 2008-04-09 CN CN200880011783A patent/CN101669032A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20100015421A (ko) | 2010-02-12 |
AU2008238258A1 (en) | 2008-10-23 |
EP2135084A1 (en) | 2009-12-23 |
JP2010523990A (ja) | 2010-07-15 |
RU2009141703A (ru) | 2011-05-20 |
US8377648B2 (en) | 2013-02-19 |
CN101669032A (zh) | 2010-03-10 |
CA2682899A1 (en) | 2008-10-23 |
AU2008238258B2 (en) | 2013-05-23 |
BRPI0810176A2 (pt) | 2014-12-30 |
WO2008125262A1 (en) | 2008-10-23 |
US20100129834A1 (en) | 2010-05-27 |
RU2484482C2 (ru) | 2013-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009010910A (es) | Regulacion autoinmune de cancer de prostata por anexina a3. | |
WO2007120362A3 (en) | Adipogenic adenoviruses as a biomarker for disease | |
WO2006052823A3 (en) | Biomarkers for prostate cancer metastasis | |
WO2011088149A3 (en) | Methods for predicting response of triple-negative breast cancer to therapy | |
WO2011082198A3 (en) | Cancer biomarkers to predict recurrence and metastatic potential | |
Nicolazzo et al. | The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) | |
WO2009032949A3 (en) | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection | |
MX341734B (es) | Biomarcadores para la prediccion de la eficacia de una inmunoterapia contra el cancer. | |
MX2009006378A (es) | Biomarcadores para cancer. | |
MX2007004176A (es) | B7-h1 y metodos de diagnosis, prognosis, y tratamiento de cancer. | |
IN2013CN01129A (es) | ||
WO2009002931A3 (en) | Methods and uses thereof of prosaposin | |
EP1910838A4 (en) | SPECIFIC CANCER GLYCANS AND THEIR USE | |
MY193914A (en) | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume | |
MA34878B1 (fr) | Utilisation de ligands sigma pour la douleur des cancers des os | |
WO2011094759A3 (en) | Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignancies | |
WO2008130887A8 (en) | Biomarkers for follicular thyroid carcinoma and methods of of use | |
WO2011139721A8 (en) | Cancer biomarkers and methods of use thereof | |
WO2014140896A3 (es) | Metodo para el diagnostico, pronostico y tratamiento de la metastasis de un cancer | |
WO2008097466A3 (en) | Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors | |
WO2018097614A3 (ko) | 유방암 환자의 화학치료 유용성 예측 방법 | |
MY195697A (en) | Method of Prognosing and Predicting Breast Cancer Recurrence, Markers Employed Therein and Kit Thereof | |
ATE525484T1 (de) | Slco1b3-genotyp | |
WO2013062261A3 (en) | Newly identified colon cancer marker and diagnostic kit using the same | |
WO2012040226A3 (en) | Gene expression in n-cadherin overexpressing prostate cancers and their controls |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |